Even Exercising a Few Times a Week Cuts Later Dementia Risk
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 31, 2024 -- The "weekend warrior" physical activity pattern is associated with a reduced risk for mild dementia over time, according to a study published online Oct. 29 in the British Journal of Sports Medicine.
Gary O'Donovan, Ph.D., from Universidad de los Andes in Bogota, Colombia, and colleagues investigated associations between the "weekend warrior" physical activity pattern and mild dementia. The analysis included 10,033 adults (mean age, 51 years) followed for 16 years.
The researchers found that compared with the group that reported no sport or exercise, risk was lower in the "weekend warrior" group (hazard ratio, 0.75; 95 percent confidence interval, 0.61 to 0.91), as well as in the regularly active group (hazard ratio, 0.89; 95 percent confidence interval, 0.78 to 1.02) and the combined group (hazard ratio, 0.84; 95 percent confidence interval, 0.75 to 0.95). Thirteen percent of dementia cases were attributable to a failure to exercise once or twice per week or more often. Results were similar for mild dementia.
"This study is important because it suggests that even busy people can gain cognitive health benefits from taking part in one or two sessions of sport and exercise per week," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.